← Back to Results BZ Pro Unusual Options Activity Market Events (1).csv  ·  Jun 29, 2026 4:24 PM
GIS BUY CALL ⚡ 13
1 trade · $210K total premium · largest $210K
AVOID / WAIT
BiasBULLISH MOMENTUM
Confidence47 / 100
Best SetupPUT 35.00 · 2026-07-17
TimeframeShort Swing (1–4 weeks)
ReadinessLow
WHY WE LIKE IT
1/1 trades appear to be new opening positions
BIGGEST RISK
⚠ Below-average Vol/OI — flow may not be as unusual as the premium size implies
· 1/1 trades are D/F grade — low conviction flow
BULLISH MOMENTUM
Short Swing (1–4 weeks)
47
LOW CONFIDENCE
SUGGESTED TRADE
BTO GIS $35C 7/17/26 @ M (scale in)
ENTRYAbove $36.61
·
STOPBelow $35.34 (−3%)
·
TARGET$39.34 (+8.0% required)
WHY
1/1 trades appear to be new opening positions
▼ BEARISH 50 BULLISH ▲
$36.42 ▲ 1.14%
ABOVE MA50
+6.6% vs MA50 -14.4% vs MA200
MA20 $33.82
MA50 $34.16
MA200 $42.55
52W $32.17
$53.83
Support $35
RSI(14) 66.2 CONFIRMING
MACD 0.260 / -0.040 BULLISH
VOL 5/20 1.07x FLAT
STRONG_CONFIRMING Chart Confirmation (30m)
Calls Bought
$0
0 trades
Calls Sold
$0
0 trades
Puts Bought
$0
0 trades
Puts Sold
$210K
1 trade
GradeDateExpiryStrikeTypeDirSentimentPremium$/ContLive $VolOIContract
D 2026-06-28 03:41:25 PM 2026-07-17 35.00 PUT SELL BULLISH $210K $0.70 3649 4581 TRADE
C/P Premium Ratio
0.00
Calls / Puts
0 / 1
Sweeps / Blocks
0 / 0
Bull / Bear
1 / 0
Avg Vol/OI
0.65
Avg DTE
19d
▮ Calls 0% Premium Split Puts 100% ▮
▮ Bullish 100% Sentiment Bearish 0% ▮
Flow by Timeframe
Scalp
0–7 DTE
No flow
Swing
8–90 DTE
$210K
1 trade
BULLISH
100% bull · 0% bought
Position
90+ DTE
No flow
Top Contracts to Consider
PUT SELL
35.00 · 2026-07-17 · $210K · Vol/OI 0.7x · 19 DTE
$210K total premium
Show 1 individual trade
Filter:
Grade Date Expiry Strike TypeActionSentimentPremium $/ContLive $ VolumeOIVol/OIContractSpot
D OPEN 2026-06-28 03:41:25 PM 2026-07-17 35.00 PUT SELL BULLISH $210K $0.70 3649 4581 0.65 TRADE 36.43
News & Filings
Date Type Headline
Jun 28 BZ Wire Stock Market Today: Nasdaq, Dow S&P 500 Futures Jump As Trump Admin Says US, Iran Will 'Stand Down' For Now— Verizon, HP, Universe Pharmaceuticals In Focus (UPDATED)